Lixin Qiu

Fudan University - Department of Medical Oncology

Shanghai, 20032

China

SCHOLARLY PAPERS

3

DOWNLOADS

234

TOTAL CITATIONS

3

Scholarly Papers (3)

1.

Phase III Trial Comparing XELOX Regimen (Oxaliplatin Plus Capecitabine) Versus EOX Regimen (Epirubicin, Oxaliplatin and Capecitabine) as First-Line Treatment for Advanced Gastric Cancer: The EXELOX Trial

Number of pages: 27 Posted: 28 Jun 2021
Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Shanxi Cancer Hospital, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, University of Science and Technology of China (USTC) - Division of Life Science and Medicine, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Soochow University - The First People’s Hospital of Changzhou, Nantong Tumor Hospital, Zhengzhou University - Department of Oncology, Fudan University - School of Public Health, Department of Biostatics, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Shanxi Cancer Hospital, University of Science and Technology of China (USTC) - Division of Life Science and Medicine, Shanxi Cancer Hospital, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Zhengzhou University - Department of Oncology, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Soochow University - The First People’s Hospital of Changzhou, Nantong Tumor Hospital, Shanxi Cancer Hospital and Fudan University - Department of Medical Oncology
Downloads 114 (526,383)
Citation 2

Abstract:

Loading...

2.

Novel Functional Variants in the Notch Pathway and Survival of Chinese Colorectal Cancer

Number of pages: 41 Posted: 03 Nov 2020
Cancer Institute, Collaborative Innovation Center for Cancer Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Fudan University - Shanghai Cancer Center (FUSCC), Key Lab of Health Technology Assessment (National Health Commission), School of Public Health, Fudan University, Cancer Institute, Collaborative Innovation Center for Cancer Medicine, Fudan University Shanghai Cancer Center, Fudan University - Department of Medical Oncology, Cancer Institute, Collaborative Innovation Center for Cancer Medicine, Fudan University Shanghai Cancer Center, Fudan University - Department of Colorectal Surgery, Duke University - Duke Cancer Institute and Fudan University - Department of Colorectal Surgery
Downloads 65 (746,811)

Abstract:

Loading...

Colorectal cancer, survival, Notch, MINAR1, single-nucleotide polymorphisms

3.

mTOR Pathway Gene Mutations Predict Response to Immune Checkpoint Inhibitors in Multiple Cancers

Number of pages: 29 Posted: 17 Jan 2022
Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Fudan University - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Fudan University - Shanghai Cancer Center (FUSCC), Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine and Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine
Downloads 55 (813,308)
Citation 1

Abstract:

Loading...

mTOR pathway, Cancer, ICI, TMB, Prognosis